228 related articles for article (PubMed ID: 27133703)
1. Endorectal multiparametric MRI of the prostate: incremental effect of perfusion imaging on biopsy target identification.
Romero G; Foster BR; Pettersson DR; Fung AW; Guimaraes AR; Coakley FV
Clin Imaging; 2016; 40(3):553-7. PubMed ID: 27133703
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
[TBL] [Abstract][Full Text] [Related]
3. Endorectal multiparametric 3-tesla magnetic resonance imaging associated with systematic cognitive biopsies does not increase prostate cancer detection rate: a randomized prospective trial.
Taverna G; Bozzini G; Grizzi F; Seveso M; Mandressi A; Balzarini L; Mrakic F; Bono P; De Franceco O; Buffi N; Lughezzani G; Lazzeri M; Casale P; Guazzoni GF
World J Urol; 2016 Jun; 34(6):797-803. PubMed ID: 26481226
[TBL] [Abstract][Full Text] [Related]
4. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
[TBL] [Abstract][Full Text] [Related]
5. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
6. Central zone lesions on magnetic resonance imaging: Should we be concerned?
Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L
Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837
[TBL] [Abstract][Full Text] [Related]
7. Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.
Kuhl CK; Bruhn R; Krämer N; Nebelung S; Heidenreich A; Schrading S
Radiology; 2017 Nov; 285(2):493-505. PubMed ID: 28727544
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score.
Osses DF; van Asten JJ; Kieft GJ; Tijsterman JD
World J Urol; 2017 Feb; 35(2):207-212. PubMed ID: 27287889
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
[TBL] [Abstract][Full Text] [Related]
10. The Value of Endorectal Magnetic Resonance Imaging of the Prostate in Improving the Detection of Anterior Prostate Cancer.
Zugor V; Kühn R; Engelhard K; Poth S; Bernat MM; Porres D; Labanaris AP
Anticancer Res; 2016 Aug; 36(8):4279-83. PubMed ID: 27466544
[TBL] [Abstract][Full Text] [Related]
11. T2- and diffusion-weighted magnetic resonance imaging at 3T for the detection of prostate cancer with and without endorectal coil: An intraindividual comparison of image quality and diagnostic performance.
Baur AD; Daqqaq T; Wagner M; Maxeiner A; Huppertz A; Renz D; Hamm B; Fischer T; Durmus T
Eur J Radiol; 2016 Jun; 85(6):1075-84. PubMed ID: 27161055
[TBL] [Abstract][Full Text] [Related]
12. Endorectal MR imaging of prostate cancer: Evaluation of tumor capsular contact length as a sign of extracapsular extension.
Mendez G; Foster BR; Li X; Shannon J; Garzotto M; Amling CL; Coakley FV
Clin Imaging; 2018; 50():280-285. PubMed ID: 29727817
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
[TBL] [Abstract][Full Text] [Related]
14. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
[TBL] [Abstract][Full Text] [Related]
16. [MRI of the prostate].
Nörenberg D; Solyanik O; Schlenker B; Magistro G; Ertl-Wagner B; Clevert DA; Stief C; Reiser MF; D'Anastasi M
Urologe A; 2017 May; 56(5):665-677. PubMed ID: 28424829
[TBL] [Abstract][Full Text] [Related]
17. Detection of Local Recurrence of Prostate Cancer After Radical Prostatectomy Using Endorectal Coil MRI at 3 T: Addition of DWI and Dynamic Contrast Enhancement to T2-Weighted MRI.
Kitajima K; Hartman RP; Froemming AT; Hagen CE; Takahashi N; Kawashima A
AJR Am J Roentgenol; 2015 Oct; 205(4):807-16. PubMed ID: 26397329
[TBL] [Abstract][Full Text] [Related]
18. Serial Magnetic Resonance Imaging in Active Surveillance of Prostate Cancer: Incremental Value.
Felker ER; Wu J; Natarajan S; Margolis DJ; Raman SS; Huang J; Dorey F; Marks LS
J Urol; 2016 May; 195(5):1421-1427. PubMed ID: 26674305
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer.
Hoffmann MA; Taymoorian K; Ruf C; Gerhards A; Leyendecker K; Stein T; Jakobs FM; Schreckenberger M
Anticancer Res; 2017 Dec; 37(12):6871-6877. PubMed ID: 29187467
[TBL] [Abstract][Full Text] [Related]
20. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
